Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 1999

View Archived Issues

MiniMed signs agreement with Lilly for insulin lispro

Dusa's Levulan effective in hair removal trials

Aurora Biosciences and Pfizer sign technology acquisition agreement

Company Profile: Neuromedica

InSite Vision's ISV-205 achieves positive results in phase II study

Bausch & Lomb to collaborate on ophthalmic drug delivery technology

Japanese authorities register first diagnostic test for Alzheimer's disease

Notice of allowance to Cypros for Cordox in bypass surgery

Hyseq and Kirin identify genes associated with cell growth factor activity

Lexicon Genetics reaches agreement with several institutions for custom knockout mice

Tramadol recommended as a safe and effective treatment for restless legs syndrome

Alexion: significant milestones reached in Q3

Corvert restores normal heart rhythm in patients with atrial fibrillation

New cell adhesion inhibitors under study at Merck

AxyS describes further research on factor Xa inhibitors

Water-soluble and orally bioavailable salt of known sigma ligand prepared at Lundbeck

Roche exercises option to redeem Genentech shares

Intracellular signal transduction inhibitors described by Ariad in recent patent literature

Duke develops new porphyrins and metal complexes thereof as antioxidants

Gensia Sicor changes name to Sicor

Sankyo synthesizes series with multiple pharmacological activities

Redox and Trima collaborate on drug development

New treatment for acute cough from Nortran enters clinical testing

Abbott to acquire Alza

New peptide compounds from Calyx are first in a potential new class of oral antidiabetics

New antidiabetic agents in the pipeline at Calyx

U.K. is first market for new formulation of Casodex

New study provides evidence supporting efficacy of cladribine in MS

UCB's levetiracetam superior to placebo in refractory partial seizures

Ovine colostrum-derived polypeptide may represent novel treatment strategy in AD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.